National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

HIV/AIDS
 Understanding
 Research
  Research Program
  Basic Research
  Epidemiology
  Prevention
  Therapeutics
  Vaccines
   Introduction and Goals
   Research Activities
   Resources for Researchers
   Funding
   Meetings
   Reports and Articles
   Advisory and Working Groups
   Clinical Trials
   Considerations Papers
   Education and Outreach
  Clinical Research
  Advisory Groups and Committees
  Partners and Collaborators
  Funding Opportunities
  Scientific Meetings, Workshops and Events


HIV/AIDS

HIV Vaccine Research and Design (HIVRAD)

Program Announcement

HIVRAD Contact Information
Michael Pensiero, Ph.D.
Phone: 301-435-3749
Fax: 301-402-3684
E-mail: mpensiero@niaid.nih.gov

Current Awardees
Barton Haynes
Centralized HIV-1 genes as vaccines
Duke University

Christopher Miller
Mechanisms of protection in live-attenuated AIDS vaccine
University of California, Davis

David Knipe
Herpesvirus as vaccine vectors for AIDS
Harvard Medical School

David Weiner
DNA vaccine for induction of mucosal responses
University of Pennsylvania

Hildegrund Ertl

Correlates of protection against SIV/SHIV challenge

Wistar Institute

 

Matthias Schnell

Functional Analysis of NSV-based HIV vectors

Thomas Jefferson University

 

Michael Cho

Characterization of immunogenic and structural properties of HIV-1 envelope

Case Western Reserve University

 

Nancy Haigwood

Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination

Oregon Health and Science University

 

Robert Whalen
Development of novel immunogens for vaccines to HIV-1
Maxygen, Inc.

R. Paul Johnson
Mechanisms of protective immunity induced by live attenuated SIV vaccine
Harvard Medical School

Ruth Ruprecht

Vaccination against mucosal HIV Clade C transmission

Harvard Medical School

 

Shan Lu

Induction of neutralizing antibodies targeting CD4 binding region of HIV-1 Envelope

University of Massachusetts Medical School, Worcester

 

Susan Barnett
Targeting neutralizing epitopes in the HIV envelope
Novartis Vaccines and Diagnostics, Inc.

 

William Olson

Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers

Progenics Pharmaceuticals, Inc.

back to top

Highlights

NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research—Nov. 3, 2009

Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009—Oct. 15, 2009

National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009—Sept. 25, 2009

See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • NIAID Funding News

  • Highlights

    NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research—Nov. 3, 2009

    Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009—Oct. 15, 2009

    National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009—Sept. 25, 2009

    See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • NIAID Funding News